CVS Health Corp (CVS)

Currency in USD
92.92
-1.40(-1.48%)
Closed·
93.00+0.08(+0.09%)
·
CVS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
92.8594.15
52 wk Range
69.51110.68
Key Statistics
Prev. Close
94.32
Open
93.6
Day's Range
92.85-94.15
52 wk Range
69.51-110.68
Volume
4.33M
Average Vol. (3m)
7.98M
1-Year Change
28.8051%
Book Value / Share
62.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CVS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
116.08
Upside
+24.92%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

CVS Health Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

24 Buy
3 Hold
0 Sell
Ratings:
27 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 116.08
(+24.92% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Buy113.00+21.61%-MaintainAug 26, 2026
JPMorgan
Buy118.00+26.99%111.00MaintainAug 12, 2026
Baird
Buy107.00+15.15%94.00MaintainAug 06, 2026
UBS
Buy126.00+35.60%122.00MaintainAug 06, 2026
Barclays
Buy108.00+16.23%106.00MaintainAug 06, 2026

CVS Health Corp SWOT Analysis


Regulatory Hurdles
Star ratings recalculations and evolving PBM regulations create uncertainty, testing management's ability to deliver margin improvements amid compliance pressures
Analyst Outlook
Price targets range from $93 to $95, with Overweight ratings reflecting confidence in the company's multi-year strategic execution
Medicare Advantage
Explore how CVS's integrated model positions it to capitalize on Medicare Advantage expansion while navigating Medicaid enrollment declines
Transformation Test
CVS pursues ambitious earnings growth to $9.50 per share by 2028, requiring margin recovery across insurance and pharmacy benefit operations
Read full SWOT analysis

CVS Health Corp Earnings Call Summary for Q2/2026

  • CVS Q2 2026 EPS of $2.58 beat estimates of $1.83 by 41%; revenue of $106.1B topped forecasts by $6.07B, up 7% YoY across all segments.
  • Full-year 2026 adjusted EPS guidance raised $0.60 to $7.90-$8.10; cash flow outlook increased $2B to at least $11.5B on turnaround momentum.
  • Shares fell 7.63% premarket to $96.45 despite beat, as investors weighed 2027 headwinds from 340B pressure and Caremark membership declines.
  • Management set 2027 adjusted EPS floor at $8.44, reaffirming mid-teens growth target through 2028 amid Aetna margin recovery and AI investments.
  • CEO Joyner emphasized shift to 'consumer-based healthcare technology business' with $20B+ tech spend planned over next decade to drive efficiency.
Last Updated: 08/05/2026, 09:18 AM
Read Full Transcript
CVS Health Corp investor slides for Q2/2026
CVS Health Q2 2026 slides
Last Update: Aug 05, 2026
See full investor slides

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
2.58 / 1.83
Revenue / Forecast
106.1B / 100.03B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.82%
Dividend Yield
2.86%
Industry Median 2.02%
Annualized Payout
2.66
Paid quarterly
5-Years Growth
+5.87%
Growth Streak

CVS Income Statement

Compare CVS to Peers and Sector

Metrics to compare
CVS
Peers
Sector
Relationship
P/E Ratio
24.3x19.5x−0.4x
PEG Ratio
3.860.220.00
Price / Book
1.5x1.9x2.6x
Price / LTM Sales
0.3x1.3x3.1x
Upside (Analyst Target)
24.8%23.9%47.0%
Fair Value Upside
Unlock−1.1%5.6%Unlock

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
673.92M52.69%63.56B
Other Institutional Investors
492.96M38.54%46.50B
Public Companies & Retail Investors
112.09M8.76%10.57B
Total
1.28B100.00%120.63B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.9.63%123,223,40911,622,432
Capital Research and Management Company9.05%115,788,85110,921,204

People Also Watch

161.61
SKHY
+2.27%
201.09
ANET
-0.57%
462.00
WDC
-1.47%
218.48
NBIS
+2.13%
227.98
NVDA
+8.74%

FAQ

What Is the CVS Health Corp (CVS) Stock Price Today?

The CVS Health Corp stock price today is 92.92 USD.

What Stock Exchange Does CVS Health Corp Trade On?

CVS Health Corp is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for CVS Health Corp?

The stock symbol for CVS Health Corp is "CVS."

Does CVS Health Corp Pay Dividends? What’s The Current Dividend Yield?

The CVS Health Corp dividend yield is 2.86%.

What Is the CVS Health Corp Market Cap?

As of today, CVS Health Corp market cap is 118.84B USD.

What Is CVS Health Corp's Earnings Per Share (TTM)?

The CVS Health Corp EPS (TTM) is 3.82.

When Is the Next CVS Health Corp Earnings Date?

CVS Health Corp will release its next earnings report on Nov 04, 2026.

From a Technical Analysis Perspective, Is CVS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has CVS Health Corp Stock Split?

CVS Health Corp has split 8 times.

How Many Employees Does CVS Health Corp Have?

CVS Health Corp has 259500 employees.

What is the current trading status of CVS Health Corp (CVS)?

As of Aug 28, 2026, CVS Health Corp (CVS) is trading at a price of 92.92 USD, with a previous close of 94.32 USD. The stock has fluctuated within a day range of 92.85 USD to 94.15 USD, while its 52-week range spans from 69.51 USD to 110.68 USD.

What Is CVS Health Corp (CVS) Price Target According to Analysts?

The average 12-month price target for CVS Health Corp is 116.08 USD, with a high estimate of 148 USD and a low estimate of 103 USD. 24 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +24.92% Upside potential.

What Is the CVS Premarket Price?

CVS's last pre-market stock price is 94.24 USD. The pre-market share volume is 7,170.00, and the stock has decreased by -0.08, or -0.08%.

What Is the CVS After Hours Price?

CVS's last after hours stock price is 93.00 USD, the stock has decreased by 0.08, or 0.09%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.